Xenon Pharmaceuticals (XENE) Competitors $37.40 +0.45 (+1.23%) Closing price 03:58 PM EasternExtended Trading$37.34 -0.06 (-0.16%) As of 05:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock XENE vs. QGEN, BBIO, ROIV, ELAN, VRNA, MRNA, RVMD, GRFS, RYTM, and ABVXShould you be buying Xenon Pharmaceuticals stock or one of its competitors? The main competitors of Xenon Pharmaceuticals include QIAGEN (QGEN), BridgeBio Pharma (BBIO), Roivant Sciences (ROIV), Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), Moderna (MRNA), Revolution Medicines (RVMD), Grifols (GRFS), Rhythm Pharmaceuticals (RYTM), and Abivax (ABVX). These companies are all part of the "pharmaceutical products" industry. Xenon Pharmaceuticals vs. Its Competitors QIAGEN BridgeBio Pharma Roivant Sciences Elanco Animal Health Verona Pharma PLC American Depositary Share Moderna Revolution Medicines Grifols Rhythm Pharmaceuticals Abivax Xenon Pharmaceuticals (NASDAQ:XENE) and QIAGEN (NYSE:QGEN) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations and earnings. Do analysts prefer XENE or QGEN? Xenon Pharmaceuticals presently has a consensus price target of $53.30, indicating a potential upside of 42.50%. QIAGEN has a consensus price target of $49.69, indicating a potential upside of 8.68%. Given Xenon Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Xenon Pharmaceuticals is more favorable than QIAGEN.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Xenon Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 3.00QIAGEN 0 Sell rating(s) 8 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.27 Is XENE or QGEN more profitable? QIAGEN has a net margin of 18.30% compared to Xenon Pharmaceuticals' net margin of 0.00%. QIAGEN's return on equity of 14.77% beat Xenon Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Xenon PharmaceuticalsN/A -38.50% -36.47% QIAGEN 18.30%14.77%8.87% Which has more volatility & risk, XENE or QGEN? Xenon Pharmaceuticals has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Comparatively, QIAGEN has a beta of 0.64, indicating that its share price is 36% less volatile than the S&P 500. Do institutionals & insiders believe in XENE or QGEN? 95.5% of Xenon Pharmaceuticals shares are held by institutional investors. Comparatively, 70.0% of QIAGEN shares are held by institutional investors. 4.1% of Xenon Pharmaceuticals shares are held by insiders. Comparatively, 9.0% of QIAGEN shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has stronger earnings & valuation, XENE or QGEN? QIAGEN has higher revenue and earnings than Xenon Pharmaceuticals. Xenon Pharmaceuticals is trading at a lower price-to-earnings ratio than QIAGEN, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXenon Pharmaceuticals$9.43M305.86-$234.33M-$3.55-10.54QIAGEN$1.98B5.14$83.59M$1.6927.05 Does the media favor XENE or QGEN? In the previous week, QIAGEN had 3 more articles in the media than Xenon Pharmaceuticals. MarketBeat recorded 6 mentions for QIAGEN and 3 mentions for Xenon Pharmaceuticals. Xenon Pharmaceuticals' average media sentiment score of 1.12 beat QIAGEN's score of 1.05 indicating that Xenon Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Xenon Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive QIAGEN 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryQIAGEN beats Xenon Pharmaceuticals on 9 of the 16 factors compared between the two stocks. Get Xenon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for XENE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XENE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XENE vs. The Competition Export to ExcelMetricXenon PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.85B$3.16B$5.80B$10.46BDividend YieldN/A2.36%5.61%4.57%P/E Ratio-10.5421.03348.5626.86Price / Sales305.86447.99549.90125.65Price / CashN/A44.8326.0131.15Price / Book3.789.8315.536.50Net Income-$234.33M-$52.82M$3.29B$271.25M7 Day Performance3.93%3.47%200.87%3.69%1 Month Performance-3.70%5.35%184.38%8.07%1 Year Performance-6.84%13.26%325.51%29.65% Xenon Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XENEXenon Pharmaceuticals2.4829 of 5 stars$37.40+1.2%$53.30+42.5%-8.0%$2.85B$9.43M-10.54210Positive NewsQGENQIAGEN4.4403 of 5 stars$45.39+0.2%$49.69+9.5%+5.3%$10.07B$1.98B26.825,765BBIOBridgeBio Pharma4.4033 of 5 stars$51.47+0.5%$63.94+24.2%+95.8%$9.79B$221.90M-12.58400ROIVRoivant Sciences3.4271 of 5 stars$13.95-0.9%$17.67+26.6%+25.6%$9.61B$29.05M-19.93860Analyst RevisionELANElanco Animal Health2.7937 of 5 stars$18.63+0.5%$17.33-6.9%+36.3%$9.21B$4.44B21.669,000Positive NewsVRNAVerona Pharma PLC American Depositary Share2.0545 of 5 stars$106.37-0.1%$109.00+2.5%+253.5%$9.17B$42.28M-107.4430Positive NewsMRNAModerna4.4576 of 5 stars$23.88+1.6%$41.81+75.1%-61.6%$9.15B$3.24B-3.175,800RVMDRevolution Medicines4.2631 of 5 stars$46.20-0.8%$73.67+59.5%-4.1%$8.70B$11.58M-10.27250GRFSGrifols3.9868 of 5 stars$9.63-2.5%$10.30+7.0%+8.8%$6.79B$7.81B8.2323,822Positive NewsRYTMRhythm Pharmaceuticals3.0519 of 5 stars$96.03-0.2%$101.57+5.8%+81.9%$6.39B$156.29M-31.90140Positive NewsABVXAbivax2.5611 of 5 stars$85.87+2.2%$99.43+15.8%+628.3%$6.35BN/A0.0061 Related Companies and Tools Related Companies QIAGEN Alternatives BridgeBio Pharma Alternatives Roivant Sciences Alternatives Elanco Animal Health Alternatives Verona Pharma PLC American Depositary Share Alternatives Moderna Alternatives Revolution Medicines Alternatives Grifols Alternatives Rhythm Pharmaceuticals Alternatives Abivax Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XENE) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredThe next AI Hype Spike is days away — don’t miss itOn this date, AI could trigger the kind of predictable surge that's already paid out 61%… 158%… and even 382% ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
